JRCT ID: jRCT2080223237
Registered date:08/06/2016
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 18/03/2016 |
Target sample size | 276 |
Countries of recruitment | Japan,Asia except Japan,North America,South America,Europe,Oceania |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : ponatinib Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | efficacy |
---|---|
Secondary Outcome | efficacy |
Key inclusion & exclusion criteria
Age minimum | >= 18age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | Takeda Development Center Americas, Inc. / CMIC Co., Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT02467270,JapicCTI-163292 |
Contact
Public contact | |
Name | |
Address | |
Telephone | - |
ClinicalTrialInformation@cmic.co.jp | |
Affiliation | |
Scientific contact | |
Name | |
Address | |
Telephone | - |
ClinicalTrialInformation@cmic.co.jp | |
Affiliation |